Harzianoic acids A and B, new natural scaffolds with inhibitory effects against hepatitis C virus.


Journal

Bioorganic & medicinal chemistry
ISSN: 1464-3391
Titre abrégé: Bioorg Med Chem
Pays: England
ID NLM: 9413298

Informations de publication

Date de publication:
01 02 2019
Historique:
received: 25 11 2018
revised: 26 12 2018
accepted: 28 12 2018
pubmed: 5 1 2019
medline: 18 12 2019
entrez: 5 1 2019
Statut: ppublish

Résumé

Two new sesquiterpene-based analogues, namely harzianoic acids A (1) and B (2), were isolated from a sponge-associated fungus Trichoderma harzianum. Their structures were determined on the basis of the extensive spectroscopic analyses in association with the ECD data for the configurational assignment. Harzianoic acids A and B were structurally characterized as a sesquiterpene and a norsesquiterpene with a cyclobutane nucleus, which is uncommonly found from nature. Both compounds exhibited the inhibitory activity to reduce the HCV RNA levels with low cytotoxicity. The preliminary investigation of the mode of action revealed that the compounds blocked the entry step in the HCV life cycle, while the viral E1/E2 and the host cell CD81 were the potential target proteins.

Identifiants

pubmed: 30606673
pii: S0968-0896(18)32003-0
doi: 10.1016/j.bmc.2018.12.038
pii:
doi:

Substances chimiques

Antiviral Agents 0
Biological Products 0
Hydroxybutyrates 0
Pyrroles 0
RNA, Viral 0
harzianic acid 157148-06-6

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

560-567

Informations de copyright

Copyright © 2018 The Authors. Published by Elsevier Ltd.. All rights reserved.

Auteurs

Bo Li (B)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.

Li Li (L)

Institute of Materia Medica, Chinese Academy of Medical Sciences, Beijing 100050, PR China.

Zonggen Peng (Z)

Institute of Medicinal Biotechnology, Chinese Academy of Medical Sciences, Beijing 100050, PR China.

Dong Liu (D)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.

Longlong Si (L)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.

Jing Wang (J)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.

Bochuan Yuan (B)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.

Jian Huang (J)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China.

Peter Proksch (P)

Institute für Pharmazeutische Biologie und Biotechnologie, Heinrich-Heine-Universität, 40225 Düsseldorf, Germany.

Wenhan Lin (W)

State Key Laboratory of Natural and Biomimetic Drugs, Peking University, Beijing 100191, PR China. Electronic address: whlin@bjmu.edu.cn.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH